This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page | Contact Us | Sign In | Join SAPAA
Virtual Conference Webinar Series
Share |

SAPAA's Board of Directors extends you a special invitation to attend our Annual Conference Webinar Series!  It's a time of adjustment for everyone, and SAPAA is looking to help by replacing our conference this year with a webinar series so these presentations may be available to as many as possible without the risk and expense of attending a live event.  From the latest on regulatory changes to the most relevant training in the industry, SAPAA is here to help!

SAPAA's Conference and Training Institute Committees have been hard at work selecting the latest topics to bring to you in a webinar platform.  All webinar sessions will be delivered through GoToWebinar, and attendees are asked to ensure their device meets the minimum requirements to attend by completing GoToWebinar's Attendee System Check.  Unless noted, all webinars will be recorded and attendees will be given access to the recording.  Even if you can't attend live, register for the session to have the recording link sent to you.  Attendees of the live webinars will have the option to participate in Q & A sessions at the end of the presentation.

If you register for a webinar that has already been hosted, you'll receive a link to view the recording.

CEU credit is provided for these sessions through:

   

Credit has been applied for with the HR Certification Institute.

 Click here to register for SAPAA's Virtual Conference Webinars!

 Recordings of past conference webinar sessions are available here.

June 17, 2020 • 2:00–3:00 p.m. (EST)

Employer Best Practices for Non-Mandated Drug Testing Programs
Presented by Penny Horton, MSOD, SHRM-SCP, C-DER
Free for SAPAA members;  $39 for non-members.

In order to achieve a workplace free from the effects of drug and alcohol abuse, employers need to understand all of the steps necessary to achieve a drug-free workplace.   This session will provide an overview of the points an employer needs to consider on everything from policy writing, to second chance determinations, to offering assistance for its employees, all while being compliant with applicable local, state, and federal guidelines.  

 


Penny has over 20 years of leadership experience, including more than ten years of proven ability, leading human resources and organizational design strategies for corporations with both domestic and international presence.   She is a Senior Certified Professional through the Society for Human Resources Management and a C-DER through DATIA.  Penny has over a decade of extensive knowledge and experience managing drug and alcohol testing programs.   She served for more than eight years as a Drug and Alcohol Program Manager for a large aerospace company, in which she had responsibility for ensuring program compliance with both the DOT/FAA and DOT/FMCSA testing regulations as well as company policy.   During this time, she successfully led the organization through multiple FAA Drug Abatement audits and inspections.   She continues to build upon those skills by offering drug and alcohol testing program management, design, consultation, and expertise to employers across Oklahoma and the United States through her company.

 


July 15, 2020 • 2:00–3:00 p.m. (EST)

Employee Screening Technologies
Presented by Joe Plaia, Joseph Plaia Consulting
Free for SAPAA members;  $39 for non-members.

With many options, buying and selling a complete line of screening services is more complex than ever.   This session will present key advantages and disadvantages of screening technologies and how to select one or more of these for a comprehensive solution.   The optimal decision is based upon matching critical needs to screening services.

 


Joe Plaia, President of Joseph Plaia Consulting, provides consulting and expertise in sales, marketing, and management within the employee screening industry.  He’s served as an industry consultant since 2013 and is also an associate with the Current Consulting Group.  Joe is the former national sales and marketing director with Roche Diagnostics, Varian, LabCorp, and Alere Toxicology.  Joe has more than 28 years of sales management and marketing experience in the employee screening industry.  He has successfully trained and managed diverse teams of sales professionals from inside sales representatives to global key account managers, as well as TPA’s, distributors, and franchise owners.

 


August 19, 2020 • 2:00–3:00 p.m. (EST)

The DER and TPA:  It’s Like a Marriage—Get a Pre-Nup, Divorce is Ugly
Presented by Joe Reilly, National Drug Screening, Inc.
Free for SAPAA members;  $39 for non-members

Employer Designated Employer Representatives (DER’s) look to their TPA’s for a smooth drug and alcohol testing program in compliance with regulations, state laws, and best practices.   This session will examine the relationship between the DER and the TPA, which can seem like a marriage.  It can be bliss, complex, and perhaps frustrating.  Each party should be clear on what each other’s responsibilities are.  Industry veteran Joe Reilly has worked with DER’s for more than 25 years and will share his experiences. 

Attendees will learn:

  • The agreement between the DER and the TPA is the pre-nup
  • Communication with the TPA saves the marriage
  • What makes a wonderful, loving TPA
  • Signs of a bad TPA
  • What makes a wonderful, loving DER
  • DER pitfalls
  • Moving into the future:  the modern drug and alcohol testing program

 

With extensive experience in drug testing since 1993, Joe Reilly is considered an expert for the workplace drug testing industry.   Joe currently services as President of National Drug Screening, Inc, President of Joe Reilly & Associates, Inc, and Senior Compliance Officer for USA Mobile Drug Testing.   Joe is a past chairman of the DATIA Board of Directors and a long time SAPAA member.  Very active in the drug and alcohol testing industry, Joe regularly provides consulting services, training programs, and expert witness testimony.   Born and raised in New York City, Joe has degrees in accounting and marketing from Manhattan College, Bronx, NY.  He currently resides in Melbourne Beach, FL, with his wife, Robin.

 


TRAINING INSTITUTE SESSION

August 24, 2020 • 10:00 a.m.–12:00 p.m. (EST)

Legal/MRO Interaction on New EEOC's Opioid Guidance Works for All Legal Drugs
Presented by Tommy Eden, Esq., Constangy, Brooks, Smith & Prophette, LLP &
C.B. Thuss, Jr., M.D., CMRO, St. Vincent’s Occupational Health Clinics
$175 for SAPAA members;  $225 for non-members. 

On August 5, 2020, the Equal Employment Opportunity Commission  issued new guidance on the rights of employees who are legally using opioids, titled: “Use of Codeine, Oxycodone, and Other Opioids:  Information for Employees.”  Although aimed at employees and health care providers, the document provides a road map for employers who have employees using any type of over-the-counter or prescription medication legally.  Because the same principles apply to all use of legal drugs*, you can replace "opioids" with "legal drugs*" in this summary of the EEOC's guidance.

In this session, presenters will walk you through the 12 principles found in the EEOC regulations and how to implement these fitness for duty principles for your business or public entity.

Note:  Medical marijuana is still illegal under federal law, which means it would not violate federal law for the employer to take action against an applicant or employee who is a current user, however, taking such action could violate applicable state law.

 

Tommy Eden is a management labor attorney with the nationwide firm of Constangy, Brooks, Smith & Prophete, LLP Workplace Drug & Alcohol Testing Practice Group.
   
  Dr. C. B. Thuss, Jr. is the Medical Director OHCI at St. Vincent’s Occupational Health Birmingham, AL.  He was one of the first certified Medical Review Officers (AAMRO) as well as one of the first D.O.T. Certified Medical Examiners.

 


TRAINING INSTITUTE SESSION

August 24, 2020 • 3:00–5:00 p.m. (EST)

Roles and Responsibilities—DER, TPA, MRO, Collector:   Managing Your Drug Testing Program by Working Together
Presented by Regina Doural, CSAPA, FSSolutions
$90 for SAPAA members;  $125 for non-members.

Hear more about this course from the presenter!

 

Are you a TPA, Collector, MRO, or DER?  This session will look at these roles as well as others involved in the drug testing process.  We will address the responsibilities of each role and how they interact with each other.  Discussions will include which tasks the employer can outsource and which are better kept in-house, and how these responsibilities may change if the employer has multiple locations or multiple programs.

This course is appropriate for:  DERs and TPAs

Why should an attendee take this course?  DERs will get an in-depth look at their responsibilities as it pertains to drug and alcohol testing.  Participants will learn what is required to be in compliance with state and federal regulations and how to interact with your service providers.

Outline of topics to be covered:

Primary responsibilities of the DER

  • Compliance
  • Training
  • Random Management
  • Testing Requirements
  • Reporting Requirements

Expectations of the collection site

Expectations of the laboratory, MRO, and SAP

Responsibilities of the MRO

Working with a TPA

Handouts provided:  Presentation slides will be emailed to registrants ahead of the course.

Presenter availability for questions:  Presenter contact information will be shared with attendees for any questions that come up after the course.

 

 
Regina Doural, CSAPA, is the General Manager of Compliance Services for FSSolutions, one of the largest privately held Third Party Administrators (TPA) in the country.  Regina has 20 years of experience in the drug and alcohol testing industry providing oversight to all areas of regulatory compliance.  Ms. Doural has created and delivered numerous training programs and webinars on drug and alcohol topics, including combatting cheating, audit preparation, and monitoring compliance as the designated employer representative (DER).   Ms. Doural is a Certified Substance Program Administrator (CSAPA) and currently serves as President for the Certification for Drug and Alcohol Program Professional (CCDAPP).  She is also on the Board of Directors for the Substance Abuse Program Administrators Association (SAPAA) and is a member of their Training Institute.

August 25, 2020 • 10:00–11:00 a.m. (EST)

ODAPC Update
Presented by Mark Snider, ODAPC
Free for SAPAA members;  $39 for non-members.

Updates and horizon issues from the Office of Drug and Alcohol Policy and Compliance.

 

  Mark Snider is the Chief of Audits and Inquiries for the U.S Department of Transportation Office of Drug and Alcohol Policy and Compliance. He started with the Federal Highway Administration (FHWA) in 1987 as a Safety Investigator, with the responsibility of enforcing the FHWA regulations against private trucking companies.  From 1991 to January 1999, he was the Drug and Alcohol Program Manager for the FHWA, which is now the Federal Motor Carrier Safety Administration (FMCSA).  Following that, he served as the Drug and Alcohol Program Manager for the Federal Transit Administration (FTA) from January 1999 until July 2003.  Mr. Snider has presented more than 250 drug and alcohol seminars and authored and co-authored several papers and documents related to drug and alcohol programs in the DOT arena.  He graduated from Shippensburg University with a Master’s Degree in Administration of Justice.


August 25, 2020 • 12:00–1:00 p.m. (EST)

SAPAA Annual Membership Meeting & 
CCDAPP Presentation of Sue Clark Award for Excellence
No charge.

Everyone is invited to attend this annual recap of the organization, which includes committee updates, recognition of volunteers, and the conclusion of the election of open positions on SAPAA’s Board of Directors.

Sue Clark Award for Excellence:  This prestigious award is given annually by The Certification Commission for Drug and Alcohol Program Professionals (CCDAPP) to a recognized leader who has made an outstanding contribution to the drug and alcohol testing industry.  Sue Clark Award winners are respected by their peers for demonstrating leadership, integrity, and high ethical standards throughout their careers and for having assisted in the professional development of future leaders in the field of substance abuse program administration.

 


August 25, 2020 • 2:00–3:00 p.m. (EST)

Drug Testing Industry Insights
Presented by R.H. Barry Sample, Ph.D., Quest Diagnostics
Free for SAPAA members;  $39 for non-members.

The Quest Diagnostics Drug Testing Index™ (DTI) provides insights into trends in workforce drug use, based on positivity results for de-identified laboratory testing performed by Quest for a range of illicit, legal, and prescription drugs.  Quest publishes these findings as a public service for government, employers, policymakers, and the general public.  Our 2020 DTI report features annual positivity data as well as an analysis of drug use by industry sector.

 


Dr. Barry Sample, Senior Director of Science and Technology, Quest Diagnostics, received his bachelor’s degree in chemistry and his doctorate in pharmacology from Indiana University and is a board-certified forensic toxicologist.  Dr. Sample joined Quest Diagnostics in 1991 and is responsible for the production and introduction of new products and services through new test and technology development.  He also publishes the Quest Diagnostics Drug Testing Index™ annually for government, policymakers, media, and the general public.  Barry is a Regional Commissioner and an inspector for the College of American Pathologists (CAP) Forensic Drug Testing (FDT) laboratory accreditation program, a member of the Tennis (ATP Tour/ITF/WTA Tour) Anti‐Doping Program Review Board, and a past president of the Substance Abuse Program Administrators Association (SAPAA).

 


August 26, 2020 • 10:00–11:00 a.m. (EST)

Workplace Drug Testing Issues and Trends
Presented by Faye Caldwell, J.D., Caldwell Everson PLLC
Free for SAPAA members;  $39 for non-members.

Overview of changes and developing trends in drug testing laws at both the state and federal levels.   The presentation will cover not only the impact of the laws, such as cannabis legislation and hemp, but also provide guidance to employers and service agents to create effective drug testing policies.

 

Faye Caldwell is the founding partner at Caldwell Everson in Houston, TX.  Faye represents clients across the drug testing industry in litigation and contested proceedings, including collectors, employers, MROs, TPAs, and laboratories.   Faye focuses her practice on practical advice and solution-based defense of drug testing industry clients in litigation and regulatory matters.  She also routinely counsels clients regarding compliance and drug testing industry best practices to mitigate risks and avoid litigation.   She has worked extensively in matters involving SAMHSA, DOT, and state law substance abuse testing and is a member of the Drug Testing Advisory Board.

 


August 26, 2020 • 2:00–3:00 p.m. (EST)

Results from the COVID-19 in the Workplace Employer and Provider Surveys:  Valuable Information to Help Prepare for the Future
Presented by Bill Current, Current Consulting Group
Free for SAPAA members;  $39 for non-members.

The COVID-19 pandemic rages on and, in the process, continues to have a direct and significant impact on drug testing practices.  Employers and service providers have been deeply affected.  As such, the Current Consulting Group (CCG), which has been conducting industry surveys for more than 22 years, decided to conduct a new and very timely survey devoted entirely to the key issues surrounding how the pandemic is affecting drug and alcohol testing programs, sales, and revenue.  

Bill Current, who founded the Current Consulting Group in 1998 and conducted the first industry survey in 1999, worked with several industry leaders to create an insightful list of questions that would illuminate the key issues employers and providers have grappled with through the first four months of the pandemic.  The survey consisted of two specific tracks, one for employers and one for service providers, which in the end produced two sets of survey results.  Issues covered by the survey include challenges with collections, marijuana testing, alternative testing practices, breath and saliva alcohol testing, and workplace COVID testing.  When combined, these surveys identify the trending challenges faced by employers and service providers and focuses attention on what they are doing to overcome those challenges.

Under the circumstances, this may be the most important industry survey in the 22 years Bill Current has been conducting surveys. “Everyone is keeping their fingers crossed that the pandemic ends soon,” Current recently said. “In the meantime, we need to find new ways to survive and be prepared for a post-pandemic drug testing industry.  I believe the results of this survey can help employers and providers better prepare for that day.” 

 

Bill Current is the author of “Why Drug Testing: Updated and Expanded for 2020,” as well as nine other books on substance-related issues.  He founded the Current Consulting Group in 1998 and it has become the number one recognized brand name in compliance and business development consulting in the drug testing industry.  He created Current Compliance, the only comprehensive on-line subscription database on all state laws related to workplace drug testing, including marijuana and workers’ compensation laws.  He is the former Executive Director of the American Council for Drug Education and Vice President of Consulting at Employee Information Services, a national drug testing provider. 

 


TRAINING INSTITUTE SESSION

August 27, 2020 • 10:00 a.m.–12:00 p.m. (EST)

How to Vet Your Service Agents
Presented by Mary Hines, CSAPA, SimplePath
$90 for SAPAA members;  $125 for non-members. 

Hear more about this course from the presenter!

 

In this course, we will dive deep into what you should be doing to vet ALL your services agents, especially in regards to collectors and BATs.   We will be discussing laboratories, MROs, TPAs, collection sites, collectors, BATs, medical examiners, and SAPs.  Seeing a certificate is never enough!

This course is appropriate for:  TPAs, DERs, collection sites

Why should an attendee take this course?  To make sure that your organization is doing this job, vetting your service agents, to the degree that it will never bite you in the rear!

Outline of topics to be covered:

Service agents defined

How to vet each type of service agent

  • TPA/Consortia
  • Collection site
  • Collector
  • BAT/STT
  • Medical Examiner
  • Laboratory
  • Medical Review Officer
  • SAP

Handouts provided:  Presentation slides, checklists, and source guide will be emailed to registrants ahead of the course.

Presenter availability for questions: Presenter contact information will be shared with attendees for any questions that come up after the course.

 

Mary Hines is an auditor, ex-TPA owner, and consultant with more than 30 years of experience dealing with verification of service agent credentials.  She is a CSAPA and tries her very best to be in the know.

 


TRAINING INSTITUTE SESSION

August 27, 2020 • 3:00–5:00 p.m. (EST)

Third Party Administrator Best Practices
Presented by Tom Pool, CSAPA, Drug Free Business
$90 for SAPAA members;  $125 for non-members. 

Hear more about this course from the presenter!

 

Do you want to start your own TPA?   Do you want to expand or improve your existing C/TPA?   Add new income streams?  Add in-house MRO services, EAP services, background screening, or ‘clean-cards’?  This session offers best practices and new ideas from a presenter with 32 years' experience as a full-service TPA.

This course is appropriate for:  TPAs who want some new ideas to expand their services, become more efficient, decrease liability risks, and become more profitable;  collectors and other service agents interested in becoming a full-service TPA;  Experienced HR professionals and DERs who want to start a small business and have often thought, “I can do that!”

Why should an attendee take this course?  No matter what your current position or role is in the drug testing industry, you can learn some tips and best practices that can make your job easier with fewer headaches and risks.  I hope you’ll put some of these to use and maybe get a promotion, become an entrepreneur, or at least sleep better.  Note:  We are not going to rehash the federal or state regulations—SAPAA has other courses for that.  This is not a “how to start your own business” course—Small Business Administration has free courses for that.

Outline of topics to be covered:

What documents and reference material you need and where to get them (most are free)

What is a TPA?

Why should you expand and offer other services?

What makes one a drug testing professional?

Drug testing labs

Written contracts or statement of services

MRO services

When is it appropriate to report a client to the authorities (DOT or state)?

Contracts

Insurance

Creating drug and alcohol policies for clients

TPA pricing plans

TPA record-keeping requirements

Additional services a TPA may provide

Handouts provided:  Presentation slides with links to documents will be provided to registrants after the course.  Bonus:  Each registrant will receive a copy of a 20-minute video, “DOT Drug & Alcohol Refresher Training,” and a license to use it when providing refresher training to their clients.

Presenter availability for questions:  Presenter contact information will be shared with attendees for any questions that come up after the course.

 

Tom Pool is the founder (1988) and now Executive Administrator of Drug Free Business, a non-profit corporation that provides drug and alcohol testing services to over 3,300 clients.  Before this, he was a Navy Intelligence Officer, police officer, detective, and now a retired Special Agent with the Drug Enforcement Administration where he was in charge of training for Texas and Oklahoma, and demand reduction coordinator for the five Pacific Northwest states.  He continues to be an advisor to the NW High Intensity Drug Trafficking Area (HIDTA).  He is a Certified Substance Abuse Program Administrator (CSAPA), a member of the SAPAA Training Institute, and Commissioner for the Certification Commission for Drug and Alcohol Program Professionals.  Over five thousand employers have attended his drug-free workplace training programs

 


TRAINING INSTITUTE SESSION

August 28, 2020 • 10:00 a.m.–12:00 p.m. (EST)

Drug & Alcohol Industry Training Course Summary  
Presented by Jeff Sims, CSAPA, Xpert Diagnostics, Inc.
$250 for SAPAA members;  $300 for non-members. 

Hear more about this course from the presenter!

 

Traditionally presented live, this full-day comprehensive training course is being made available in 4 individual modules.  Modules will be released to registrants beginning the week of August 3rd, and should be viewed before this summary webinar.  Attendees will have the opportunity to ask questions individually along the way, but there will also be plenty of time for questions during this summary.

This course is appropriate for:  Anyone looking to gain familiarity with the drug and alcohol testing industry, from the elementary to the advanced.  This course is especially helpful for those preparing to take the CSAPA exam.  

Why should an attendee take this course?  For an incredibly in-depth course that explains all facets of our industry, including regulated and non-regulated.

Outline of topics to be covered: 

History of workplace testing

Specimen collection

Laboratory procedures

Role of the Medical Review Officer and Substance Abuse Professional

Alcohol testing

Emerging technologies

DOT modal differences.

Handouts provided:  Presentation slides and handouts will be emailed to attendees with each module.

Presenter availability for questions: Presenter contact information will be shared with attendees for any questions that come up after the course.

 

Jeff Sims, CSAPA is the President of Xpert Diagnostics, Inc.  He serves on the Board of Directors for the Substance Abuse Program Administrators Association (SAPAA) and as a Commissioner for the Certification Commission for Drug and Alcohol Program Professionals (CCDAPP).

 


September 16, 2020 • 2:00–3:00 p.m. (EST)

The Care and Feeding of Your SAP
Presented by Laura Lacey Dashner, LCSW, American Substance Abuse Professionals, Inc.
Free for SAPAA members;  $39 for non-members.

Join us as we work to bridge the gap between SAPs, DERs, and MROs.   Excellent communication between these parties is critical to the success of the DOT Return-to-Duty Process, yet such communication can often be challenging.  This training is designed to address that gap by bringing the SAP perspective to you and by listening for the needs of the industry.  We will field questions and propose solutions to common pain points in the process.  

 

Laura Dashner is the Chief Executive Officer and President of American Substance Abuse Professionals. Ms. Dashner started with ASAP in August of 2003 after receiving her MSW from the University of Maryland with a specialization in EAP studies. As a licensed social worker, she is an experienced DOT qualified Substance Abuse Professional and NRC qualified Substance Abuse Expert. Ms. Dashner has worked closely with DOT regulated client companies, NRC nuclear licensees, and EAPs in a wide variety of fields to implement effective substance use risk management programs. As a recognized expert in her field, Ms. Dashner has developed and facilitated DOT SAP qualification trainings, SAP and SAE continuing education classes and other presentations related to the industry for organizations such as the Substance Abuse Program Administrators Association (SAPAA) Annual Conference, the Texas Association of Addiction Professionals, the Employee Assistance Professionals Association (EAPA) SBIRT Webinar Series, the Chesapeake Chapter of EAPA, the Cape Cod Symposium on Addictive Disorders and the Drug and Alcohol Testing Industry Association (DATIA) Annual Conference.

 


October 21, 2020 • 2:00–3:00 p.m. (EST)

Practical Approaches to Oral Fluid Testing
Presented by Brian Feeley, OraSure Technologies &
Jackie Pirone, OraSure Technologies
Free for SAPAA members;  $39 for non-memb ers.

In this webinar, we will cover:

  • An overview of oral fluid drug testing
  • Self-collection of oral fluid—threat vs. opportunity for collectors
  • Oral fluid guidelines update
  • Safety of oral fluid and COVID-19 testing

 

Brian is the Director of Sales for OraSure Technologies’ Substance Abuse Testing division.  He has over 35 years’ experience in the industry working in technical, business development, and sales and marketing capacities.  He is named as an inventor of four patents in the diagnostics field and has numerous publications.  Brian has been at OraSure Technologies for the past 23 years, where he has focused on providing oral fluid drugs of abuse and alcohol testing products.  Brian and his team educate and train national laboratory partners, TPA’s and end users on the benefits of oral fluid testing to enhance their substance abuse screening programs.
   
  Jackie Pirone is Program Leader for OraSure Technologies’ Substance Abuse testing division.  She has over 25 years’ experience in the drug testing industry, working at OraSure for the past 10 years and Roche Diagnostics Corporation for 15 years.  Jackie is responsible for the global marketing direction, as well as the financial and market growth of the drugs of abuse and risk assessment product lines at OraSure.

 


November 18, 2020 • 2:00–3:00 p.m. (EST)

Operationalizing a Science-Based Understanding of Addiction for the Workplace
Presented by Karen Pierce, M.A., M.S.W., Working Partners®
Free for SAPAA members;  $39 for non-memb ers.  This session will NOT be recorded.

Thanks to new technology, researchers can SEE how addiction damages the brain.  With these advancements, scientists now know that substance use disorder—addiction—is a preventable, chronic, treatable medical condition.   This can be a challenging reframe for employers to accept after decades of programming that runs counter to this new information.   Discover how treating addiction like other chronic medical conditions can impact your business policies, operations, health, and profitability of your workplace and workforce.

 

Karen Pierce is the Managing Director of Working Partners®, a training and consulting firm specializing in helping workplaces address the risks associated with the harmful use of substances. She also served as Director of the Drug-Free Workforce Community Initiative, a public-private partnership with the Ohio Department of Mental Health and Addiction Services to address the economic threat of substance abuse by employees and job seekers in our state.

 


December 16, 2020 • 2:00–3:00 p.m. (EST)

Leading Your Organization to Safety: Addressing Marijuana Abuse and COVID-19 in the Workplace
A Guide to Maintaining a Safe and Healthy Workplace
Presented by Bill Current, Current Consulting Group & 
Joe Plaia, Joseph Plaia Consulting
Free for SAPAA members;  $39 for non-memb ers.

Session information will be updated soon.

 

Bill Current is the author of “Why Drug Testing: Updated and Expanded for 2020,” as well as nine other books on substance-related issues.  He founded the Current Consulting Group in 1998 and it has become the number one recognized brand name in compliance and business development consulting in the drug testing industry.  He created Current Compliance, the only comprehensive on-line subscription database on all state laws related to workplace drug testing, including marijuana and workers’ compensation laws.  He is the former Executive Director of the American Council for Drug Education and Vice President of Consulting at Employee Information Services, a national drug testing provider. 
   
  Joe Plaia, President of Joseph Plaia Consulting, provides consulting and expertise in sales, marketing, and management within the employee screening industry.  He’s served as an industry consultant since 2013 and is also an associate with the Current Consulting Group.  Joe is the former national sales and marketing director with Roche Diagnostics, Varian, LabCorp, and Alere Toxicology.  Joe has more than 28 years of sales management and marketing experience in the employee screening industry.  He has successfully trained and managed diverse teams of sales professionals from inside sales representatives to global key account managers, as well as TPA’s, distributors, and franchise owners.